Skip to content

Usefulness of telemedicine in hypertensive outpatients: Cluster randomized controlled trial

Usefulness of telemedicine in hypertensive outpatients: Cluster randomized controlled trial - Usefulness of telemedicine in hypertensive outpatients: Cluster randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040953
Enrollment
70
Registered
2020-07-31
Start date
2020-05-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Intervention group: Telemedicine at the 3rd month from the baseline. Control group: Face-to-face outpatient service at the 3rd month from the baseline.

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Adult patients receiving outpatient telemedicine and adult patients who will start outpatient telemedicine (2) Adult patients who have been diagnosed with essential hypertension and are prescribed antihypertensive drugs for 3 months or more (3) Adult patients with stable hypertension and co-morbidities (no change in prescription of antihypertensive drug for 3 months) (4) Adult patients who can visit the clinic 3 and 6 months after registration (5) Those who have taken a sufficient explanation to participate in this research, and have a sufficient understanding and consent

Exclusion criteria

Exclusion criteria: (1) Patients with drug allergy (2) Pregnant patients (3) Patients who can not undertaken telemedicine, such as those with visual impairment (4) Patients with end stage renal failure (5) Cancer receiving chemotherapy (6) Patients with chronic respiratory disease such as obstructive pulmonary disease with home oxygen therapy (7) Patients participating in other clinical trials (8) Patients who need frequent outpatient visit such as blood tests (9) Patients who the principal investigator and co-investigators judged to be medically or scientifically inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
Changes in systolic blood pressure (value after 6 months vs baseline)

Secondary

MeasureTime frame
Patient satisfaction and economic analysis in medicine

Countries

Japan

Contacts

Public ContactYuji Nishizaki

Juntendo University Medical Technology Innovation Center

ynishiza@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026